Chronic Constipation: Causes, Myths and What Really Gets Things Moving

Chronic Constipation: Causes, Myths and What Really Gets Things Moving

For many people living with inflammatory bowel disease (IBD), bowel habits become something to monitor closely, and not all changes point to flare-ups. Chronic constipation, infrequent or difficult bowel movements lasting weeks or months, can happen alongside Crohn’s disease or ulcerative colitis, sometimes for reasons that have little to do with active inflammation. Understanding what actually drives constipation, rather than relying on common assumptions, helps patients and clinicians address it more effectively.

What is chronic constipation?

Chronic constipation is generally defined as having fewer than three bowel movements a week, straining, passing hard stools, or feeling incomplete emptying, persisting for at least three months. It is one of the most common digestive complaints, affecting a substantial proportion of adults at some point. In IBD, it can occur even when inflammation is well controlled, which is why it should not automatically be read as a sign that disease activity is worsening.

Why it matters for gut inflammation

The gut relies on coordinated muscle contractions, called peristalsis, to move waste through the digestive tract. When transit slows, stool remains in contact with the bowel lining for longer, which can alter the balance of gut bacteria (the microbiome) and increase pressure on the intestinal wall. In people with IBD, this matters because a narrowed or scarred section of bowel, known as a stricture, can mimic or worsen constipation, and unresolved constipation can add physical strain to tissue that may already be inflamed or healing. It is also worth noting that symptoms such as bloating or reduced stool frequency do not always equal inflammation; they can reflect muscular, structural, or functional changes that require a different kind of assessment.

Key mechanisms

Slow transit constipation

This occurs when the nerves and muscles controlling movement through the colon become less responsive, so waste moves through more slowly than normal. It can be linked to age, reduced physical activity, certain medications, or long-standing changes in gut motility. In IBD, previous surgery or long periods of reduced mobility during illness can contribute to this pattern.

Pelvic floor dysfunction

The pelvic floor is a group of muscles that support the bowel and help coordinate the release of stool. When these muscles fail to relax properly during defecation, a condition called dyssynergic defecation, stool can become difficult to pass even when transit through the colon is otherwise normal. This is more common after pelvic surgery or in people who have spent years managing urgency and straining, both of which can happen in IBD.

Strictures and structural narrowing

In Crohn’s disease particularly, chronic inflammation can lead to fibrosis, a build-up of scar tissue that narrows the bowel. This structural narrowing can slow or block the passage of stool, producing symptoms that look like constipation but stem from a mechanical, rather than functional, cause. Strictures usually need to be identified through imaging or endoscopy rather than managed with diet alone.

Medication-related constipation

Several medications commonly used in IBD care, including certain pain relievers (particularly opioids), iron supplements, and some anti-nausea drugs, can slow gut motility as a side effect. Recognising this link matters because the solution may involve adjusting medication rather than increasing fibre or fluid intake alone.

Diet, fibre and hydration myths

A persistent myth is that all constipation responds to simply adding more fibre. In reality, insoluble fibre can worsen symptoms in people with strictures or slow transit by adding bulk that is harder to move. Soluble, fermentable fibres and adequate fluid intake tend to be better tolerated, but the right approach depends on the underlying cause and current disease activity. Fibre changes in IBD should generally be tailored with a dietitian rather than applied generically.

Practical Takeaways

  • Track bowel frequency and stool consistency over time rather than reacting to a single difficult day.
  • Discuss any new or worsening constipation with your IBD team before assuming it is diet-related, particularly if you have Crohn’s disease or a history of strictures.
  • Review current medications with your clinician, as pain relief or iron supplementation may be contributing.
  • Introduce dietary changes gradually and under guidance, especially around fibre type and quantity.
  • Stay consistently hydrated rather than increasing fluid intake only when symptoms appear.
  • Maintain regular, moderate physical activity where possible, as this supports normal gut motility.

Conclusion

Chronic constipation in IBD is rarely caused by one single factor, and it does not automatically signal a flare. Slow transit, pelvic floor function, structural narrowing, and medication effects can all play a role, often overlapping. Identifying the underlying mechanism, rather than applying generic fibre or laxative advice, leads to more effective and sustainable management. Working with a gastroenterologist or dietitian familiar with IBD ensures that changes are appropriate to both bowel structure and disease activity.

References

  1. Bharucha AE, Wald A. Chronic constipation. Mayo Clin Proc. 2019;94(11):2340-2357. doi:10.1016/j.mayocp.2019.01.031.
  2. Sood R, Ford AC. Chronic constipation in inflammatory bowel disease: assessment and management. Frontline Gastroenterol. 2021;12(4):315-321. doi:10.1136/flgastro-2019-101271.
  3. Rao SSC, Bharucha AE, Chiarioni G, et al. Functional anorectal disorders. Gastroenterology. 2016;150(6):1430-1442. doi:10.1053/j.gastro.2016.02.009.
  4. Bosch S, de Meij TG, Kort D, et al. Fibrostenotic Crohn’s disease: pathogenesis and management. Dig Dis Sci. 2020;65(11):3143-3155. doi:10.1007/s10620-020-06561-w.
  5. El-Salhy M, Gundersen D. Diet in irritable bowel syndrome and functional constipation. Nutr J. 2015;14:36. doi:10.1186/s12937-015-0022-3.
  6. Camilleri M, Ford AC, Mawe GM, et al. Chronic constipation. Nat Rev Dis Primers. 2017;3:17095. doi:10.1038/nrdp.2017.95.

This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.

About the Author

Team Vance

Team Vance is the editorial team at Vance Medical, the medical foods company behind this hub. Vance Medical has spent more than thirty years in gastrointestinal medicine, developing nutritional products under the same regulatory frameworks that govern prescription medicines. The Hub exists to make that ground accessible, to people living with Crohn's disease, ulcerative colitis, IBS and related conditions, and to the clinicians treating them. Articles are written and edited in-house, and clinical claims are referenced to published research, with each study linked to its DOI so you can read the source rather than take our word for it. We publish primarily for a UK audience. Nothing here replaces advice from your own GP, gastroenterologist or dietitian.

For general information only. This article is for general information and is not a substitute for professional medical advice, diagnosis or treatment. It reflects the best available evidence at the time of writing and may not capture the most recent developments. Always talk to your GP, pharmacist or health team before acting on anything you read here, and never disregard professional advice or delay seeking it because of something on this site. Where we mention products from Vance Medical Foods Ltd we identify this clearly.
Last updated 15 September 2026
×
×